Back to Blackstone Inc. Blackstone Inc.

LXEOLXEO
11 quarters

Position history for Blackstone Inc.Blackstone Inc.'s holdings in LEXEO THERAPEUTICS INC

Blackstone Inc. holds 904,959 shares of LXEO (LEXEO THERAPEUTICS INC), worth $4.2M as of 2026-Q2. LXEO represents 0.0% of Blackstone Inc.'s portfolio.

Current Value

$4.2M

Current Shares

904,959

Total Value Change

-$5.1M

Total Shares Change

+208,849

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
904,959
0.0%
$4.2M0.0%$4.66
0
2026-Q1
Unchanged
904,959
0.0%
$5.2M0.0%$7.07
0
2025-Q4
Decreased
904,959
-19.6%
$9M0.0%$9.74
0
2025-Q3
Unchanged
1.1M
0.0%
$7.5M0.0%$6.66
0
2025-Q2
Decreased
1.1M
-2.9%
$4.5M0.0%$4.12
0
2025-Q1
Unchanged
1.2M
0.0%
$4M0.0%$4.10
0
2024-Q4
Unchanged
1.2M
0.0%
$7.6M0.0%$6.54
0
2024-Q3
Increased
1.2M
+43.8%
$10.5M0.0%$9.11
37
2024-Q2
Increased
805,757
+15.8%
$12.9M0.1%$16.04
32
2024-Q1
Unchanged
696,110
0.0%
$10.9M0.0%$15.68
0
2023-Q4
New
696,110
-
$9.3M0.0%$13.42
38

Other major holders of LXEO: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used